Lilly Acquires Phase III Intranasal Glucagon from Locemia Solutions
Eli Lilly and Company (NYSE: LLY) and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia’s intranasal glucagon. […]
Eli Lilly and Company (NYSE: LLY) and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia’s intranasal glucagon. […]